hematology – pharmaceutical daily

July 3, 2019 Off

Takeda to Demonstrate Global Leadership in Hematology at ISTH 2019

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, will present research covering a broad range of rare bleeding disorders at the 27th Annual International Society on Thrombosis and Haemostasis Congress

November 1, 2018 Off

Quicker pathway to a pivotal trial for larger patient population than planned for Actinium’s CD33

By Dino Mustafić

@ActiniumPharma moves to next stage of development for its CD33 ARC (Antibody Radiation Conjugate) Ac-225-Lintuzumab program are pivotal trial pathway for its Actimab-MDS program for Myelodysplastic Syndromes (MDS), and also in two combination trials with Venetoclax for AML.
$ATNM

February 21, 2017 Off

$100 million for Global HOPE to treat children with cancer and blood disorders, training for 4,800 healthcare pros in Africa

By Dino Mustafić

Botswana will be a centert for southern and east Africa for hematology-oncology treatment, as it will get a new $100…